Citadel Advisors’s Stantec STN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,900
Closed -$205K 14023
2025
Q3
$205K Sell
1,900
-6,600
-78% -$721K ﹤0.01% 11211
2025
Q2
$924K Buy
8,500
+6,300
+286% +$607K ﹤0.01% 7280
2025
Q1
$182K Sell
2,200
-2,500
-53% -$200K ﹤0.01% 10583
2024
Q4
$369K Buy
+4,700
New +$390K ﹤0.01% 9240
2024
Q3
Sell
-900
Closed -$75.2K 15208
2024
Q2
$75.2K Sell
900
-7,500
-89% -$611K ﹤0.01% 11280
2024
Q1
$698K Buy
8,400
+1,600
+24% +$131K ﹤0.01% 7672
2023
Q4
$545K Buy
6,800
+3,900
+134% +$270K ﹤0.01% 7910
2023
Q3
$188K Buy
2,900
+2,400
+480% +$160K ﹤0.01% 10008
2023
Q2
$32.6K Hold
500
﹤0.01% 12269
2023
Q1
$29.2K Sell
500
-2,900
-85% -$157K ﹤0.01% 12757
2022
Q4
$163K Buy
+3,400
New +$164K ﹤0.01% 10479

Other funds holding STN

Citadel Advisors's STN Position: Q1 2026 in Review

Citadel Advisors increased its Stantec (STN) stake by 112% in Q1 2026, buying an estimated $15.2M and bringing the position to 307,054 shares worth $26.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Citadel Advisors first reported a position in STN in Q1 2015 and has held it in 24 quarters since. 308 funds tracked by Wall St. Rank hold STN as of Q1 2026.

  • Citadel Advisors held 307,054 shares of Stantec worth $26.5M as of Q1 2026.
  • Citadel Advisors bought 162,133 Stantec shares in Q1 2026, an estimated $15.2M.
  • Stantec made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #1986 holding.
  • Citadel Advisors first reported a position in Stantec in Q1 2015 and has held it in 24 quarters since.
  • 308 funds tracked by Wall St. Rank held Stantec as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.